Primary Record
pentazocine
- In stock
- 6,704 g
- Purity
- 98.8 %
- CAS
- 359-83-1
Compound Identifiers & Properties
- CAS
- 359-83-1
- PubChem CID
- 66387
- SMILES
- CC1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O
- Canonical SMILES
- CC(C)=CCN1CC[C@]2(C)c3cc(O)ccc3C[C@H]1C2C
Names & Synonyms
- pentazocine
- Fortalgesic
- Fortalin
- Sosigon
- Talwin
- Pentazocin
- Pentazocina
- Pentazocinum
- Pentagin
- Fortral
- Liticon
- Sosegon
- Soseton
- dl-Pentazocine
- Pentazocina [DCIT]
- Pentazocinum [INN-Latin]
- UNII-RP4A60D26L
- AC1L259C
- C19H27NO
- II-C-2
- HSDB 3150
- WIN 20228
- 2-(3,3-Dimethylallyl)cyclazocine
- Pentazocine (1mg/ml in Methanol)
- C19-H27-N-O
- CID66387
- NIH 7958
- Pentazocine [USAN:BAN:INN:JAN]
- Pentazocine [USAN:INN:BAN:JAN]
- EINECS 206-634-6
- CS-O-02130
- KF-1820
- NSC 107430
- NSC-107430
- Pentazocine [USAN:USP:INN:BAN:JAN]
- PD018339
- NS00126059
- cis-( inverted exclamation markA)-Pentazocine
- 2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan
- 359-83-1
- 2'-Hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan
- 2-(3,3-Dimethylallyl)-2',2'-hydroxy-5,9-dimethyl-6,7-benzomorphan
- (2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol
- (2R,6R,11R)-rel-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-2,6-methano-3-benzazocin-8-ol
- 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol
- 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11- dimethyl-3-(3-methyl-2-butenyl)-, (2?,6?,11R*)-
- 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-
- 3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol
- Pentazocine; (2RS,6RS,11RS)-6,11-dimethyl-3-(3-methylbut-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol; 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-rel-; 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2R,6R,11R)-rel- (9CI); 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2a,6a,11R*)- (8CI); (+/-)-Pentazocine; 1,2,3,4,5,6-Hexahydro-3-(3-methyl-2-butenyl)-6,11-dimethyl-8-hydroxy-2,6-methano-3-benzazocine; 1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol; 2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan; 2'-Hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan; 3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol; 3-(3-Methyl-2-butenyl)-1,2,3